BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• BioCapital

  OpGen Announces Closing of $12M Public Offering

  H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

  February 7, 2018

   · 

  4 min read
• Drug Development

  Bavarian Nordic Announces Positive Results of Pivotal Phase III Study of IMVAMUNE Smallpox Vaccine

  In this randomized, open-label study of 440 volunteers, the peak neutralizing antibodies induced by IMVAMUNE were shown to be 2-fold higher than those stimulated by ACAM2000.

  February 7, 2018

   · 

  6 min read
• Drug Development

  Follicum Phase IIa Study of FOL-005 Against Hair Loss on Scalp Approved by the German Medicines Agency

  Follicum today announced it has received approval from the German Medicines Agency and German Ethics Committee to commence a Phase IIa clinical trial in Germany with its lead candidate FOL-005 on patients with Alopecia.

  February 7, 2018

   · 

  1 min read
• Planmed Launches Improved Planmed Verity CBCT Scanner

  Planmed is proud to present the improved Planmed Verity CBCT scanner – a unique 3D imaging solution for orthopedic as well as head and neck imaging.

  February 7, 2018

   · 

  3 min read
• 

  Deals

  Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M

  Elastagen’s revolutionary technology is based on recombinant human tropoelastin, the precursor of elastin which is a key component of youthful skin.

  February 7, 2018

   · 

  4 min read
• Business

  Alkermes to Host Conference Call to Discuss Fourth Quarter and Year-End 2017 Financial Results

  The webcast player and accompanying slides may be accessed on the Investors section of Alkermes’ website at www.alkermes.com.

  February 7, 2018

   · 

  1 min read
• BioMidwest

  Sysmex to Improve Animal Hematology With New Products

  Sysmex America, a trusted leader in clinical laboratory solutions that optimize efficiency, announced today that it will distribute the CellaVision DM9600 Vet and CellaVision DM1200 Vet analyzers.

  February 7, 2018

   · 

  2 min read
• Business

  Cate Lockhart Appointed Program Director of Biologics and Biosimilars Collective Intelligence Consortium (BBCIC)

  The Biologics and Biosimilars Collective Intelligence Consortium is pleased to announce that Cate Lockhart, PharmD, PhD, has been appointed BBCIC Program Director.

  February 7, 2018

   · 

  2 min read
• Edmond De Rothschild Investment Partners Closes EUR 345 Million BioDiscovery 5 fund

  BioDiscovery 5 includes investments from current and new investors, with investors representing more than 60% of BioDiscovery 4 choosing to reinvest in BioDiscovery 5.

  February 7, 2018

   · 

  2 min read
• Business

  ProBioGen and TEVA Sign License Agreement on Human Artificial Lymph Node Technology

  The unique human Artificial Lymph Node model was developed by ProBioGen as superior 3D-micro-organoid model for analyzing substance effects on the human immune system in vitro.

  February 7, 2018

   · 

  3 min read